Therapy Areas: Oncology
DNV issues IVDR certificate for FAMID Biomedical Technology's E7 Oncoprotein Rapid Test Kit
19 November 2026 -

DNV, an EU Notified Body for the In Vitro Diagnostic Medical Devices Regulation (IVDR), announced on Wednesday that it has issued an IVDR certificate to China-based FAMID Biomedical Technology (Tianjin) Co Ltd for its diagnostic test designed to support the early detection of cervical cancer.

According to DNV, the certification was completed in just six months, following assessment of the manufacturer's quality management system, clinical evidence and technical documentation.

FAMID Biomedical's newly certified E7 Oncoprotein Rapid Test Kit, classified as a Class C in vitro diagnostic medical device under the IVDR, is designed as an aid in the diagnosis of cervical epithelial cell lesions through the detection of HPV E7 oncoprotein in cervical cell samples. The product is intended for both professional laboratory use and self-testing.

Login
Username:

Password: